Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.
Wang X, Venet D, Lifrange F, Larsimont D, Rediti M, Stenbeck L, Dupont F, Rouas G, Garcia AJ, Craciun L, Buisseret L, Ignatiadis M, Carausu M, Bhalla N, Masarapu Y, Villacampa EG, Franzén L, Saarenpää S, Kvastad L, Thrane K, Lundeberg J, Rothé F, Sotiriou C.
Wang X, et al.
Nat Commun. 2024 Nov 26;15(1):10232. doi: 10.1038/s41467-024-54145-w.
Nat Commun. 2024.
PMID: 39592577